Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
61.74
+1.74 (2.90%)
At close: Feb 27, 2026, 4:00 PM EST
62.67
+0.93 (1.51%)
After-hours: Feb 27, 2026, 5:30 PM EST
Vaxcyte Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 98.33, with a low estimate of 38 and a high estimate of 137. The average target predicts an increase of 59.26% from the current stock price of 61.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $85 → $89 | Strong Buy | Maintains | $85 → $89 | +44.15% | Feb 26, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $116 | Strong Buy | Reiterates | $116 | +87.88% | Feb 2, 2026 |
| Needham | Needham | Strong Buy Maintains $90 → $110 | Strong Buy | Maintains | $90 → $110 | +78.17% | Jan 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +37.67% | Nov 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $160 → $85 | Strong Buy | Maintains | $160 → $85 | +37.67% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
17.00M
Revenue Next Year
2.08M
from 17.00M
Decreased by -87.74%
EPS This Year
-6.47
from -5.63
EPS Next Year
-6.74
from -6.47
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 157.5M | 15.0M | |||
| Avg | 17.0M | 2.1M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | -11.7% | |||
| Avg | - | -87.7% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -4.81 | -6.02 | |||
| Avg | -6.47 | -6.74 | |||
| Low | -8.24 | -7.34 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.